Patent · US Expired

Use of angelicin and of its structural analogues for the treatment of thalassemia

US7572827B2 · kind B2 · utility

2Cited by

2References

2Claims

0Family size

Assignees

UNIVERSITA' DEGLI STUDI DI FERRARA · IT
Associazione Veneta per la Lotta Alla Talassemia · IT

Inventors

Nicoletta Bianchi · Mezzogoro, IT
Monica Borgatti · Ferrara, IT
Roberto Gambari · Bologna, IT
Ilaria Lampronti · Ferrara, IT

Key dates

Filing date	Jul 30, 2003
Grant date	Aug 11, 2009
Priority date	—
Expiry date	Sep 11, 2024

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P7/06
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The use of angelicin and its structural analogues for the preparation of a medicament for the therapeutic treatment of beta-thalassaemia is described. A structural analogue which is particularly preferred for this purpose is bergapten.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.